Showing results (971-980 of 6,492) with videos related to
Sort By:
Pageof 650
Journal of Thrombosis and Haemostasis : JTH|April 23, 2013
Confirmation of initial antiphospholipid antibody positivity depends on the antiphospholipid antibody profileV Pengo, A Ruffatti, T Del Ross, et al.Journal of Thrombosis and Haemostasis : JTH|April 23, 2013
Thrombotic complications of myeloproliferative neoplasms: risk assessment and risk-guided managementA Casini, P Fontana, T P LecompteJournal of Thrombosis and Haemostasis : JTH|May 8, 2013
Next-generation sequencing study finds an excess of rare, coding single-nucleotide variants of ADAMTS13 in patients with deep vein thrombosisL A Lotta, G Tuana, J Yu, et al.Journal of Thrombosis and Haemostasis : JTH|April 12, 2013
Edoxaban for the long-term treatment of venous thromboembolism: rationale and design of the Hokusai-venous thromboembolism study--methodological implications for clinical trialsG Raskob, H Büller, M Prins, et al.Journal of Thrombosis and Haemostasis : JTH|April 13, 2013
40K glycoPEGylated, recombinant FVIIa: 3-month, double-blind, randomized trial of safety, pharmacokinetics and preliminary efficacy in hemophilia patients with inhibitorsR Ljung, F A Karim, K Saxena, et al.Journal of Thrombosis and Haemostasis : JTH|April 13, 2013
β2 -Glycoprotein I binds to thrombin and selectively inhibits the enzyme procoagulant functionsN Pozzi, L Acquasaliente, R Frasson, et al.Journal of Thrombosis and Haemostasis : JTH|April 13, 2013
The predictive ability of bleeding risk stratification models in very old patients on vitamin K antagonist treatment for venous thromboembolism: results of the prospective collaborative EPICA studyD Poli, E Antonucci, S Testa, et al.Journal of Thrombosis and Haemostasis : JTH|April 16, 2013
Antithrombin is protective against myocardial ischemia and reperfusion injuryJ Wang, Y Wang, J Wang, et al.Journal of Thrombosis and Haemostasis : JTH|March 5, 2013
A new cell culture-based assay quantifies vitamin K 2,3-epoxide reductase complex subunit 1 function and reveals warfarin resistance phenotypes not shown by the dithiothreitol-driven VKOR assayA Fregin, K J Czogalla, J Gansler, et al.Journal of Thrombosis and Haemostasis : JTH|February 13, 2013
Enhancing the pharmacokinetic properties of recombinant factor VIII: first-in-human trial of glycoPEGylated recombinant factor VIII in patients with hemophilia AA Tiede, B Brand, R Fischer, et al.Pageof 650